Education
About Us
Working with TipRanks
Follow Us
TMSL - ETF AI Analysis
Top Page
T. Rowe Price Small-Mid Cap ETF (TMSL)
Rating:67Neutral
Price Target:―
Positive Factors
Strong Top Holdings
Several of the ETF's largest positions, such as Rambus and InterDigital, have delivered strong year-to-date performance, supporting overall fund returns.
Sector Diversification
The ETF spreads its investments across multiple sectors, including Technology, Industrials, and Health Care, reducing reliance on any single industry.
Healthy Year-to-Date Performance
The fund has shown solid year-to-date growth, indicating strong momentum in its portfolio.
Negative Factors
High Geographic Concentration
With over 99% of its holdings in U.S. companies, the ETF lacks exposure to international markets, limiting diversification.
Underperforming Holdings
Some top holdings, such as Corpay Inc and Renaissancere Holdings, have struggled with weak or negative year-to-date performance, dragging on overall returns.
Moderate Expense Ratio
The ETF’s expense ratio is higher than some low-cost alternatives, which could eat into long-term returns.
TMSL vs. SPDR S&P 500 ETF (SPY)
AUM1.15B
RegionNorth America
Expense Ratio0.55%
Beta1.02
IssuerT. Rowe Price
Inception DateJun 15, 2023
Dividend Yield0.39%
Asset ClassEquity
Index TrackedNo Underlying Index
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume168,649
30 Day Avg. Volume175,914
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
42.55Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering272
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
TMSL Summary
The T. Rowe Price Small-Mid Cap ETF (TMSL) focuses on small to mid-sized companies in the U.S., offering exposure to businesses that are often innovative and growing but not as prominent as large-cap companies. It includes a diverse range of industries like technology, healthcare, and financials, with top holdings such as MKS and Tenet Healthcare. This ETF is a great choice for investors looking to diversify their portfolio and potentially benefit from the growth of emerging companies. However, it’s important to note that small and mid-sized companies can be more volatile, meaning their stock prices may rise and fall more sharply than larger, established firms.
How much will it cost me?The T. Rowe Price Small-Mid Cap ETF (TMSL) has an expense ratio of 0.55%, which means you’ll pay $5.50 per year for every $1,000 invested. This is higher than average for ETFs because it is actively managed, meaning professional managers select investments rather than tracking a passive index.
What would affect this ETF?The T. Rowe Price Small-Mid Cap ETF (TMSL) could benefit from economic growth and innovation in sectors like technology and health care, which are heavily represented in its holdings. However, it may face challenges from rising interest rates or economic slowdowns, which can negatively impact smaller companies and more volatile industries such as consumer cyclical and financials. Additionally, its U.S.-focused exposure makes it sensitive to domestic regulatory changes and market conditions.
TMSL Top 10 Holdings
The T. Rowe Price Small-Mid Cap ETF (TMSL) leans heavily into technology and industrials, which together make up a significant portion of its holdings. Insmed is the fund’s standout performer, riding strong momentum and investor optimism, while TechnipFMC also adds a spark with its steady upward trend. On the flip side, Tenet Healthcare and Rambus have been lagging recently, creating some drag on overall performance. With its focus on U.S.-based small and mid-sized companies, the fund captures the innovative spirit of emerging businesses but remains vulnerable to sector-specific volatility.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| MKS | 1.38% | $16.00M | $10.94B | 43.77% | 75 Outperform | |
| Tenet Healthcare | 1.20% | $13.89M | $18.46B | 46.31% | 73 Outperform | |
| Renaissancere Holdings | 1.11% | $12.94M | $12.21B | -3.76% | 78 Outperform | |
| APi Group | 1.11% | $12.86M | $16.40B | 49.16% | 74 Outperform | |
| Popular | 1.06% | $12.33M | $7.75B | 17.95% | 75 Outperform | |
| TechnipFMC | 1.05% | $12.22M | $18.62B | 49.55% | 80 Outperform | |
| Natera | 1.05% | $12.16M | $33.75B | 42.51% | 69 Neutral | |
| Rambus | 1.01% | $11.74M | $10.94B | 78.20% | 78 Outperform | |
| Corpay Inc | 0.99% | $11.53M | $21.73B | -16.04% | 75 Outperform | |
| Webster Financial | 0.98% | $11.44M | $10.08B | 5.95% | 78 Outperform |
TMSL Technical Analysis
Positive
―
Price Trends
35.14
Positive
34.67
Positive
32.91
Positive
Market Momentum
0.35
Negative
62.83
Neutral
91.56
Negative
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For TMSL, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 35.16, equal to the 50-day MA of 35.14, and equal to the 200-day MA of 32.91, indicating a bullish trend. The MACD of 0.35 indicates Negative momentum. The RSI at 62.83 is Neutral, neither overbought nor oversold. The STOCH value of 91.56 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TMSL.
TMSL Peer Comparison
Comparison Results
Performance Comparison
TMSL
T. Rowe Price Small-Mid Cap ETF
36.29
2.31
6.80%
CGUS
Capital Group Core Equity ETF
―
―
―
QQQI
NEOS Nasdaq 100 High Income ETF
―
―
―
JMEE
JPMorgan Market Expansion Enhanced Equity ETF
―
―
―
SMIG
AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF
―
―
―
CGMM
Capital Group U.S. Small and Mid Cap ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents